View in EDS

Humoral and cellular responses to a fifth bivalent SARS-CoV-2 vaccine dose in patients with immune-mediated inflammatory diseases on tumour necrosis factor inhibitors: a prospective cohort study.

Saved in:
Bibliographic Details
Title: Humoral and cellular responses to a fifth bivalent SARS-CoV-2 vaccine dose in patients with immune-mediated inflammatory diseases on tumour necrosis factor inhibitors: a prospective cohort study.
Authors: Ørbo HS; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., de Matos Kasahara T; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Wolf AS; Section of Immunology, Norwegian Institute of Public Health, Oslo, Norway., Bjørlykke KH; Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway., Sexton J; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway., Jyssum I; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Tveter AT; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway., Solum G; Section of Immunology, Norwegian Institute of Public Health, Oslo, Norway., Kjønstad IF; Section of Immunology, Norwegian Institute of Public Health, Oslo, Norway., Bhandari S; Section of Immunology, Norwegian Institute of Public Health, Oslo, Norway., Christensen IE; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Kvien TK; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Lind A; Department of Microbiology, Oslo University Hospital, Oslo, Norway., Kared H; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Immunology, Oslo University Hospital, Oslo, Norway., Jahnsen J; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway., Haavardsholm EA; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Munthe LA; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Immunology, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B Cell Malignancies, and Precision Immunotherapy Alliance (PRIMA), University of Oslo, Norway., Provan SA; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Section for Public Health, Inland Norway University of Applied Sciences, Elverum, Norway., Vaage JT; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Immunology, Oslo University Hospital, Oslo, Norway., Mjaaland S; Section of Immunology, Norwegian Institute of Public Health, Oslo, Norway., Syversen SW; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Institute of Health and Society, Faculty of Medicine, University of Oslo, Oslo, Norway., Jørgensen KK; Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway., Grødeland G; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Immunology, Oslo University Hospital, Oslo, Norway., Goll GL; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Institute of Health and Society, Faculty of Medicine, University of Oslo, Oslo, Norway.
Source: The Lancet regional health. Europe [Lancet Reg Health Eur] 2024 Nov 15; Vol. 48, pp. 101121. Date of Electronic Publication: 2024 Nov 15 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: [Oxford] Country of Publication: England NLM ID: 101777707 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-7762 (Electronic) Linking ISSN: 26667762 NLM ISO Abbreviation: Lancet Reg Health Eur Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39624496
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Humoral and cellular responses to a fifth bivalent SARS-CoV-2 vaccine dose in patients with immune-mediated inflammatory diseases on tumour necrosis factor inhibitors: a prospective cohort study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ørbo+HS%22">Ørbo HS</searchLink>; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22de+Matos+Kasahara+T%22">de Matos Kasahara T</searchLink>; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Wolf+AS%22">Wolf AS</searchLink>; Section of Immunology, Norwegian Institute of Public Health, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Bjørlykke+KH%22">Bjørlykke KH</searchLink>; Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway.<br /><searchLink fieldCode="AU" term="%22Sexton+J%22">Sexton J</searchLink>; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Jyssum+I%22">Jyssum I</searchLink>; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Tveter+AT%22">Tveter AT</searchLink>; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Solum+G%22">Solum G</searchLink>; Section of Immunology, Norwegian Institute of Public Health, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Kjønstad+IF%22">Kjønstad IF</searchLink>; Section of Immunology, Norwegian Institute of Public Health, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Bhandari+S%22">Bhandari S</searchLink>; Section of Immunology, Norwegian Institute of Public Health, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Christensen+IE%22">Christensen IE</searchLink>; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Kvien+TK%22">Kvien TK</searchLink>; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Lind+A%22">Lind A</searchLink>; Department of Microbiology, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Kared+H%22">Kared H</searchLink>; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Immunology, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Jahnsen+J%22">Jahnsen J</searchLink>; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway.<br /><searchLink fieldCode="AU" term="%22Haavardsholm+EA%22">Haavardsholm EA</searchLink>; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Munthe+LA%22">Munthe LA</searchLink>; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Immunology, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B Cell Malignancies, and Precision Immunotherapy Alliance (PRIMA), University of Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Provan+SA%22">Provan SA</searchLink>; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Section for Public Health, Inland Norway University of Applied Sciences, Elverum, Norway.<br /><searchLink fieldCode="AU" term="%22Vaage+JT%22">Vaage JT</searchLink>; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Immunology, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Mjaaland+S%22">Mjaaland S</searchLink>; Section of Immunology, Norwegian Institute of Public Health, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Syversen+SW%22">Syversen SW</searchLink>; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Institute of Health and Society, Faculty of Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Jørgensen+KK%22">Jørgensen KK</searchLink>; Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway.<br /><searchLink fieldCode="AU" term="%22Grødeland+G%22">Grødeland G</searchLink>; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Immunology, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Goll+GL%22">Goll GL</searchLink>; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Institute of Health and Society, Faculty of Medicine, University of Oslo, Oslo, Norway.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101777707%22">The Lancet regional health. Europe</searchLink> [Lancet Reg Health Eur] 2024 Nov 15; Vol. 48, pp. 101121. <i>Date of Electronic Publication: </i>2024 Nov 15 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22[Oxford]%22">[Oxford] </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101777707 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2666-7762 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226667762%22">26667762 </searchLink><i>NLM ISO Abbreviation: </i>Lancet Reg Health Eur <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39624496
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.lanepe.2024.101121
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 101121
    Titles:
      – TitleFull: Humoral and cellular responses to a fifth bivalent SARS-CoV-2 vaccine dose in patients with immune-mediated inflammatory diseases on tumour necrosis factor inhibitors: a prospective cohort study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ørbo HS
      – PersonEntity:
          Name:
            NameFull: de Matos Kasahara T
      – PersonEntity:
          Name:
            NameFull: Wolf AS
      – PersonEntity:
          Name:
            NameFull: Bjørlykke KH
      – PersonEntity:
          Name:
            NameFull: Sexton J
      – PersonEntity:
          Name:
            NameFull: Jyssum I
      – PersonEntity:
          Name:
            NameFull: Tveter AT
      – PersonEntity:
          Name:
            NameFull: Solum G
      – PersonEntity:
          Name:
            NameFull: Kjønstad IF
      – PersonEntity:
          Name:
            NameFull: Bhandari S
      – PersonEntity:
          Name:
            NameFull: Christensen IE
      – PersonEntity:
          Name:
            NameFull: Kvien TK
      – PersonEntity:
          Name:
            NameFull: Lind A
      – PersonEntity:
          Name:
            NameFull: Kared H
      – PersonEntity:
          Name:
            NameFull: Jahnsen J
      – PersonEntity:
          Name:
            NameFull: Haavardsholm EA
      – PersonEntity:
          Name:
            NameFull: Munthe LA
      – PersonEntity:
          Name:
            NameFull: Provan SA
      – PersonEntity:
          Name:
            NameFull: Vaage JT
      – PersonEntity:
          Name:
            NameFull: Mjaaland S
      – PersonEntity:
          Name:
            NameFull: Syversen SW
      – PersonEntity:
          Name:
            NameFull: Jørgensen KK
      – PersonEntity:
          Name:
            NameFull: Grødeland G
      – PersonEntity:
          Name:
            NameFull: Goll GL
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 11
              Text: 2024 Nov 15
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2666-7762
          Numbering:
            – Type: volume
              Value: 48
          Titles:
            – TitleFull: The Lancet regional health. Europe
              Type: main
ResultId 1